Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Summary not available.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) has announced a conference call scheduled for April 28, 2023, at 11:00 AM ET to discuss its first-quarter results. Results will be publicly released before the market opens on the same day. The call will be led by CEO Ted Harris and CFO Martin Bengtsson, and will be available for replay until May 12, 2023. Interested parties can join the call by dialing 1-877-407-8289 or 1-201-689-8341. Balchem operates across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on developing specialty ingredients to enhance health and well-being across various industries worldwide.
Balchem Corporation (NASDAQ: BCPC) reported impressive fourth quarter financial results for 2022, with net sales of $232.5 million, up 9.1% from $213.1 million in Q4 2021. However, net earnings decreased to $21.4 million from $24.9 million, although adjusted net earnings rose to $30.3 million from $27.8 million. For the full year, net sales increased 17.9% to a record $942.4 million, while net earnings rose 9.6% to $105.4 million. The company achieved record sales across all three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Balchem also maintained a strong cash flow and continues to focus on strategic growth initiatives.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on February 24, 2023, at 11:00 AM ET to discuss its fourth quarter results. These results will be released before the market opens on the same day. The call will be hosted by Ted Harris (CEO) and Martin Bengtsson (CFO). Investors can join by dialing 1-877-407-8289, and the session will be available for replay until March 10, 2023. Balchem specializes in developing and marketing specialty ingredients across Human Nutrition, Animal Nutrition, and Specialty Products sectors, aiming to enhance health and well-being globally.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) CFO Martin Bengtsson will present at the CJS Securities 23rd Annual "New Ideas for the New Year" Investor Conference on January 11, 2023, starting at 11:00 AM EST. The presentation will be accessible on Balchem's website post-conference. Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, with three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) announced a dividend of $0.71 per share on December 5, 2022, marking a 10.9% increase from the previous year. This dividend will be paid on January 20, 2023, to shareholders on record as of December 27, 2022. The announcement signifies the fourteenth consecutive annual dividend increase, highlighting the company's robust financial performance and the Board's confidence in its long-term strategies.
Balchem Corporation (NASDAQ: BCPC) reported a net earnings increase to $25.2 million for Q3 2022, compared to $25.0 million in Q3 2021. Adjusted net earnings rose to $32.4 million, up 8% year-over-year, with adjusted EBITDA at $53.8 million, reflecting an 11.2% increase.
Net sales reached $244.3 million, a 23.4% increase driven by growth in all segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The effective tax rate declined to 18.8%. Cash flows from operations were $41.6 million, with free cash flow at $26.8 million.
Balchem Corporation (NASDAQ: BCPC) will host a conference call on November 4, 2022, at 11:00 AM ET to discuss its third quarter results. The financial results will be released before market opening on the same day. Interested parties can join the call by dialing 1-877-407-8289 or 1-201-689-8341 locally. A replay will be available until November 18, 2022, using conference ID #13733850. Balchem focuses on developing specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.